Literature DB >> 11145447

Diagnostic delay in pediatric malignancies--a population-based study.

H Thulesius1, J Pola, A Håkansson.   

Abstract

This study describes the discovery and diagnosis of malignant tumors from a primary care perspective in a Swedish county. Between 1984 and 1995, 68 children between the ages 0-16 years were diagnosed with a malignant tumor giving an incidence of 14/100,000. Patient records from both primary care and hospital were analyzed for 64 children. Leukemia was diagnosed in 25 children, and brain tumors in 22 children. In 68% of the children the diagnostic process was initiated in primary care, and in 32% in specialist care. Median parent's delay (time from first symptoms to first consultation), and median doctor's delay (time from first consultation to diagnosis) were 5 and 3 weeks for children with brain tumors, and 1 and 0 weeks for children with leukemia. Median lag time (parent's + doctor's delay) was 9 weeks for patients with brain tumors and 3 weeks for children with leukemia.

Entities:  

Mesh:

Year:  2000        PMID: 11145447     DOI: 10.1080/028418600750063640

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  10 in total

1.  Getting care to children with cancer: Barriers and solutions.

Authors:  Mark L Greenberg
Journal:  Paediatr Child Health       Date:  2006-03       Impact factor: 2.253

2.  Risk of childhood cancer with symptoms in primary care: a population-based case-control study.

Authors:  Rachel M Dommett; Theresa Redaniel; Michael C G Stevens; Richard M Martin; William Hamilton
Journal:  Br J Gen Pract       Date:  2013-01       Impact factor: 5.386

Review 3.  Psychiatric symptoms causing delay in diagnosing childhood cancer: two case reports and literature review.

Authors:  T B Hensgens; E Bloemer; A Y N Schouten-van Meeteren; C M Zwaan; C Van den Bos; C Huyser; G J L Kaspers
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-01-08       Impact factor: 4.785

4.  Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study.

Authors:  Jean-François Brasme; Martin Chalumeau; François Doz; Brigitte Lacour; Dominique Valteau-Couanet; Stephan Gaillard; Olivier Delalande; Nozar Aghakhani; Christian Sainte-Rose; Stéphanie Puget; Jacques Grill
Journal:  Eur J Pediatr       Date:  2011-05-03       Impact factor: 3.183

5.  Presenting symptoms of children with cancer: a primary-care population-based study.

Authors:  Jette Møller Ahrensberg; Rikke Pilegaard Hansen; Frede Olesen; Henrik Schrøder; Peter Vedsted
Journal:  Br J Gen Pract       Date:  2012-07       Impact factor: 5.386

6.  Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome.

Authors:  Jean-Francois Brasme; Jacques Grill; Francois Doz; Brigitte Lacour; Dominique Valteau-Couanet; Stephan Gaillard; Olivier Delalande; Nozar Aghakhani; Stéphanie Puget; Martin Chalumeau
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  The experience in nicaragua: childhood leukemia in low income countries-the main cause of late diagnosis may be "medical delay".

Authors:  C De Angelis; C Pacheco; G Lucchini; M Arguello; V Conter; A Flores; A Biondi; G Masera; F Baez
Journal:  Int J Pediatr       Date:  2012-02-12

Review 8.  Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis.

Authors:  James A Prior; Hoda Ranjbar; John Belcher; Sarah L Mackie; Toby Helliwell; Jennifer Liddle; Christian D Mallen
Journal:  BMC Med       Date:  2017-06-28       Impact factor: 8.775

9.  Use of primary care during the year before childhood cancer diagnosis: a nationwide population-based matched comparative study.

Authors:  Jette Møller Ahrensberg; Morten Fenger-Grøn; Peter Vedsted
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

10.  'Shouting from the roof tops': a qualitative study of how children with leukaemia are diagnosed in primary care.

Authors:  Rachel T Clarke; Caroline Hd Jones; Christopher D Mitchell; Matthew J Thompson
Journal:  BMJ Open       Date:  2014-02-18       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.